D'autres livres qui pourraient vous intéresser

• 

  How To Promote Your Business &...

  Professor Andy

  • 0
  • 0
  • 0

  WE ARE PLEASED TO PRESENT a new Book: How To Promote Your Business & Increase Sales: An excellent Sales Promotion & Social Media Marketing Book for Business Owners & Managers. This is the new and expanded 2nd Edition published in December 2022. 
   In this book, Professor Andy and his team teach readers how to effectively promote their brands on social media, retain customers, create promotional content, and market their products. 
  Their focus is on businesses that provide high-quality products and excellent customer service by brands such as Staples, Apple Stores, Target Stores, Office Depot, Google, and more.  
  In this Book, You will learn:Effective Promotions on Social Media68 Easy Ways to Retain customers350 ways to promote books or coursesEmail newsletters, blogs, postcardsAnd much more to look forward to 
  This book is dedicated to our wonderful medical professionals: doctors, nurses and all healthcare providers who helped save millions of lives during the COVID-19 pandemic of 2019 and 2020. 
  This book is a great gift for business owners and managers. It is available in Softcover, Hardcover, eBook, and Audiobook.  How To Promote Your Business & Increase Sales is currently available at Amazon, Barnes & Noble, Google Play Store and other retailers. It contains 217 pages of interesting and valuable information. Order yours today. Thank you. 

  Voir livre

• 

  Caribbean Economics - Challenges...

  Anya Solace

  • 0
  • 0
  • 0

  Challenges and Opportunities (3 in 1) offers an in-depth exploration of the complex economic conditions and future prospects in Puerto Rico, Mexico, and Venezuela. This volume takes readers through the dynamic and turbulent economic histories of these three regions, shedding light on their shared struggles, unique opportunities, and the challenges they face in a rapidly changing global economy. 
  The economic landscape of Puerto Rico is deeply impacted by its unique status as a U.S. territory, grappling with fiscal crises, high debt, and questions about its political future. Mexico presents a story of transformation, navigating economic instability, labor issues, and its path toward modernization, while balancing global trade agreements like NAFTA with internal challenges such as inequality and corruption. Venezuela’s economic troubles, once driven by vast oil wealth, now tell a cautionary tale of mismanagement, political instability, hyperinflation, and a humanitarian crisis, making it one of the most pressing economic cases in Latin America. 
  This book provides critical insights into the economic landscapes of these nations, offering a broad understanding of the factors shaping their economies, the policy choices they face, and the challenges and opportunities that lie ahead.

  Voir livre

• 

  Essential Milton Friedman The...

  Steven E. Landsburg

  • 0
  • 0
  • 0

  When economists are called “influential,” it usually means they’ve changed the way other economists think. By that standard, Milton Friedman was one of the most influential economists of all time. He revolutionized the way economists 
  think about consumption, about money, about stabilization policy, and about unemployment. He demonstrated the power of committing oneself to a few simple assumptions about human behaviour and then relentlessly pursuing their logical implications. He developed and taught new ways of interpreting data, testing his theories by their ability to explain multiple disparate phenomena. His successes were spectacular and his techniques were widely emulated. 
  It would take several large volumes to do justice to Friedman’s extraordinary contributions to economic theory, economic practice, economic policy, and economic literacy. The few brief chapters that follow will give an overview of what those volumes might contain.

  Voir livre

• 

  The Softer Side of Leadership -...

  Eugene B. Habecker

  • 0
  • 0
  • 0

  Many who lead or who aspire to lead rightly champion the importance of hard skills. These are skills that are informed by quantitative measurement and analytical thinking, among others. Knowing the numbers, embracing leadership tasks, and implementing the right strategies are important but no longer enough to be an effective leader. Indeed, the best of the leadership literature consistently emphasizes the importance of soft skills as this quote illustrates: "The capabilities required of top leaders include new and often 'softer' skills that are rarely explicitly recognized or fostered in the corporate world." (Harvard Business Review, July-August, 2022, p.42)
  In The Softer Side of Leadership, Dr. Habecker, who spent 35 consecutive years as a CEO of two universities and one large NYC non-profit, makes the case for the integration of soft skills into every aspect of the leader's personal life and the organizational agenda. He draws from his own experience, that of other international colleagues, the leadership literature, and from the Scriptures.
  The first part of the book focuses on the soft skills that help to continuously fuel the healthy development of the leader's spiritual, mental, physical, and emotional foundations. The second part focuses on the skills that drive organizational effectiveness and contribute to healthier cultures. Each chapter includes "The Chapter Idea" summary and a practical application: "Putting the Idea to Work."
  The essential idea of the book is this: As readers develop their soft skill competencies, including the skills, behaviors, practices, and disciplines presented in The Softer Side of Leadership, and combine them with their hard skill competencies, they will be better equipped to be more effective as leaders which will likely result in both healthier personal lives and healthier organizations.

  Voir livre

• 

  Bad Company - Private Equity and...

  Megan Greenwell

  • 0
  • 0
  • 0

  A timely work of singular reportage and a damning indictment of the private equity industry told through the stories of four American workers whose lives and communities were upended by the ruinous effects of private equity takeovers. 
  Private equity runs our country, yet few Americans have any idea how ingrained it is in their lives. Private equity controls our hospitals, daycare centers, supermarket chains, voting machine manufacturers, local newspapers, nursing home operators, fertility clinics, and prisons. The industry even manages highways, municipal water systems, fire departments, emergency medical services, and owns a growing swath of commercial and residential real estate. 
  Private equity executives, meanwhile, are not only among the wealthiest people in American society, but have grown to become modern-day barons with outsized influence on our politics and legislation. CEOs of firms like Blackstone, Carlyle, KKR, and Apollo are rewarded with seats in the Senate and on the boards of the country’s most august institutions; meanwhile, entire communities are hollowed out as a result of their buyouts. Workers lose their jobs. Communities lose their institutions. Only private equity wins. 
  Acclaimed journalist Megan Greenwell’s Bad Company unearths the hidden story of private equity by examining the lives of four American workers that were devastated as private equity upended their employers and communities: a Toys R Us floor supervisor, a rural doctor, a local newspaper journalist, and an affordable housing organizer. Taken together, their individual experiences also pull back the curtain on a much larger project: how private equity reshaped the American economy to serve its own interests, creating a new class of billionaires while stripping ordinary people of their livelihoods, their health care, their homes, and their sense of security. 
  In the tradition of deeply human reportage like Matthew Desmond’s Evicted, Megan Greenwell pulls back the curtain on shadowy multibillion dollar private equity firms, telling a larger story about how private equity is reshaping the economy, disrupting communities, and hollowing out the very idea of the American dream itself. Timely and masterfully told, Bad Company is a forceful rebuke of America’s most consequential, yet least understood economic forces.

  Voir livre

• 

  The Shocking Truth about...

  Zoey Fraisers

  • 0
  • 0
  • 0

  Pharmaceutical trials are essential to the development of new drugs and treatments, providing the necessary data to ensure they are safe and effective for public use. These trials have evolved over centuries, from rudimentary experiments to the sophisticated, multi-phase studies we see today. They are the cornerstone of modern medicine, influencing the drugs that populate our pharmacies and hospitals. However, the process is not without its flaws, and the history of pharmaceutical trials is marked by ethical concerns, controversy, and a complex relationship between researchers, pharmaceutical companies, and patients. 
    
  The primary goal of pharmaceutical trials is to test new drugs and therapies on human participants to gather data on their safety, efficacy, and potential side effects. These trials follow a strict protocol, designed to minimize risks while maximizing the quality of the data collected. The process typically begins with preclinical testing in laboratories, followed by clinical trials involving human subjects. These trials are divided into several phases, each designed to answer different scientific questions. From small-scale phase I trials to large-scale phase III studies, the data gathered at each stage is critical in determining whether a drug is ready for approval by regulatory authorities. 
    
  However, the path from laboratory to pharmacy shelves is not always smooth. The influence of pharmaceutical companies looms large over clinical trials, as they fund many studies and are often the driving force behind research agendas. While their involvement has led to groundbreaking advancements in medicine, it has also raised concerns about conflicts of interest and the integrity of trial data. In some cases, financial pressures have led to the manipulation or suppression of results that could impact a drug’s approval.

  Voir livre